Although different clinical studies have produced results favoring PCT as a monitoring marker in sepsis and respiratory infections [13-15], there is currently a lack of widely-accepted cut-offs, that is, actionable biomarker levels, which would allow meaningful integration of PCT kinetics into patient prognostication in critical care. The gene discussed is CALCA; the disease is respiratory tract infectious disorder.